$BICL.TA BIOCANCELL THERAPEUTICS INC. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOCANCELL THERAPEUTICS INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOCANCELL THERAPEUTICS INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in BIOCANCELL THERAPEUTICS INC. for free.
IRS Number: 204630076
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: BICL.TA
Company Address: BECK SCIENCE CENTER 8 HARTOM STREET, HAR HOTZVIM JERUSALEM 97775
Market Capitalization: $6.04B
Prev close: $118.40
Average Daily Volume: 37,356
Days Low: $114.80
Year Low: $0.61
Year High: $122.00
BIOCANCELL THERAPEUTICS INC. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 07 2012 | BICL.TA | BIOCANCELL THERAPE ... | Clal Biotechnology Industries ... | 10% Owner | Buy | P | 0.22 | 10,731,726 | 2,328,785 | 27,323,134 | 16.6 M to 27.3 M (+64.68 %) |
| Aug 07 2012 | BICL.TA | BIOCANCELL THERAPE ... | Clal Biotechnology Industries ... | 10% Owner | Buy | C | 0.22 | 4,147,171 | 899,936 | 16,591,408 | 12.4 M to 16.6 M (+33.33 %) |
| Mar 28 2012 | BICL.TA | BIOCANCELL THERAPE ... | Hochberg Abraham | Chief Scientist | Option Exercise | A | 0.00 | 300,000 | 0 | 480,000 | |
| Mar 28 2012 | BICL.TA | BIOCANCELL THERAPE ... | Hochberg Abraham | Chief Scientist | Option Exercise | A | 0.00 | 60,000 | 0 | 180,000 | |
| Mar 28 2012 | BICL.TA | BIOCANCELL THERAPE ... | Burgin Jonathan | Chief Financial Off ... | Option Exercise | A | 0.00 | 300,000 | 0 | 300,000 | |
| Mar 28 2012 | BICL.TA | BIOCANCELL THERAPE ... | Ben-Am Monique | VP Clinical Develop ... | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
| Mar 07 2012 | BICL.TA | BIOCANCELL THERAPE ... | Clal Biotechnology Industries ... | 10% Owner | Buy | J | 0.00 | 410,392 | 0 | 12,444,237 | 12 M to 12.4 M (+3.41 %) |
| Mar 07 2012 | BICL.TA | BIOCANCELL THERAPE ... | Clal Biotechnology Industries ... | 10% Owner | Buy | P | 0.26 | 8,199,400 | 2,131,844 | 12,444,237 | 4.2 M to 12.4 M (+193.16 %) |
| Mar 08 2011 | BICL.TA | BIOCANCELL THERAPE ... | Ohana Patricia | VP Clinical Develop ... | Option Exercise | A | 0.00 | 70,888 | 0 | 290,888 | |
| Mar 08 2011 | BICL.TA | BIOCANCELL THERAPE ... | Weinstein Ira | CFO and COO | Option Exercise | A | 0.00 | 20,000 | 0 | 170,000 | |
| Aug 30 2010 | BICL.TA | BIOCANCELL THERAPE ... | Boim Aviv | Director | Option Exercise | A | 0.72 | 3,464,385 | 2,494,357 | 3,464,385 | |
| Aug 30 2010 | BICL.TA | BIOCANCELL THERAPE ... | Boim Aviv | Director | Option Exercise | A | 0.72 | 4,301,906 | 3,097,372 | 4,301,906 | |
| Aug 30 2010 | BICL.TA | BIOCANCELL THERAPE ... | Boim Aviv | Director | Option Exercise | A | 0.85 | 20,000 | 17,000 | 20,000 | |
| Aug 30 2010 | BICL.TA | BIOCANCELL THERAPE ... | Boim Aviv | Director | Buy | P | 500,000.00 | 800,463 | 400,231,500,000 | 800,463 | 0 to 800.5 K |
| Apr 29 2010 | BICL.TA | BIOCANCELL THERAPE ... | NEVO DORON | Director | Option Exercise | A | 0.00 | 168,750 | 0 | 168,750 |